Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy

Human Molecular Genetics

Volumn 19, Issue 21, 2010, Pages 4207-4215

  Menazza, Sara ^a   Blaauw, Bert ^a,b   Tiepolo, Tania ^a   Toniolo, Luana ^a   Braghetta, Paola ^a   Spolaore, Barbara ^c   Reggiani, Carlo ^a   di Lisa, Fabio ^a   Bonaldo, Paolo ^a   Canton, Marcella ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c CRIBI Biotechnology Centre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); MUSCLE PROTEIN; PARGYLINE; REACTIVE OXYGEN METABOLITE; TROPOMYOSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART FAILURE; IMMUNOELECTROPHORESIS; MALE; MITOCHONDRION; MOUSE; MUSCLE CONTRACTILITY; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; COLLAGEN TYPE VI; MICE; MICE, KNOCKOUT; MONOAMINE OXIDASE; MUSCULAR DYSTROPHY, ANIMAL; MYOFIBRILS; OXIDATIVE STRESS; PHENOTYPE;

MUS;

EID: 77957870248     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq339     Document Type: Article

References (38)

1. Durbeej, M. and Campbell, K.P. (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev., 12, 349-361.
2. Bonaldo, P., Braghetta, P., Zanetti, M., Piccolo, S., Volpin, D. and Bressan, G.M. (1998) Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum. Mol. Genet., 7, 2135-2140.
3. Rando, T.A. (2002) Oxidative stress and the pathogenesis of muscular dystrophies. Am. J. Phys. Med. Rehabil., 81, S175-S186.
4. Whitehead, N.P., Yeung, E.W. and Allen, D.G. (2006) Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin. Exp. Pharmacol. Physiol, 33, 657-662.
5. Tidball, J.G. and Wehling-Henricks, M. (2007) The role of free radicals in the pathophysiology of muscular dystrophy. J. Appl. Physiol., 102, 1677-1686.
6. Messina, S., Bitto, A., Aguennouz, M., Mazzeo, A., Migliorato, A., Polito, F., Irrera, N., Altavilla, D., Vita, G.L., Russo, M. et al. (2009) Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone. Exp. Neurol., 220, 349-358.
7. Whitehead, N.P., Pham, C., Gervasio, O.L. and Allen, D.G. (2008) N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J. Physiol., 586, 2003-2014.
8. Disatnik, M.H., Dhawan, J., Yu, Y., Beal, M.F., Whirl, M.M., Franco, A.A. and Rando, T.A. (1998) Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J. Neurol. Sci., 161, 77-84.
9. Millay, D.P., Sargent, M.A., Osinska, H., Baines, C.P., Barton, E.R., Vuagniaux, G., Sweeney, H.L., Robbins, J. and Molkentin, J.D. (2008) Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat. Med., 14, 442-447.
10. Palma, E., Tiepolo, T., Angelin, A., Sabatelli, P., Maraldi, N.M., Basso, E., Forte, M.A., Bernardi, P. and Bonaldo, P. (2009) Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice. Hum. Mol. Genet., 18, 2024-2031.
11. Irwin, W.A., Bergamin, N., Sabatelli, P., Reggiani, C., Megighian, A., Merlini, L., Braghetta, P., Columbaro, M., Volpin, D., Bressan, G.M. et al. (2003) Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat. Genet., 35, 367-371.
12. Youdim, M.B., Edmondson, D. and Tipton, K.F. (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci., 7, 295-309.
13. Bianchi, P., Kunduzova, O., Masini, E., Cambon, C., Bani, D., Raimondi, L., Seguelas, M.H., Nistri, S., Colucci, W., Leducq, N. and Parini, A. (2005) Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation, 112, 3297-3305.
14. Kaludercic, N., Takimoto, E., Nagayama, T., Feng, N., Lai, E.W., Bedja, D., Chen, K., Gabrielson, K.L., Blakely, R.D., Shih, J.C. et al. (2010) Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ. Res., 106, 193-202.
15. Canton, M., Neverova, I., Menabò, R., Van Eyk, J.E. and Di Lisa, F. (2004) Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am. J. Physiol. Heart Circ. Physiol., 286, H870-H877.
16. Canton, M., Skyschally, A., Menabo, R., Boengler, K., Gres, P., Schulz, R., Haude, M., Erbel, R., Di Lisa, F. and Heusch, G. (2006) Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur. Heart J., 27, 875-881.
17. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G. and Barnard, P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science, 244, 1578-1580.
18. Weller, B., Karpati, G. and Carpenter, S. (1990) Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol. Sci., 100, 9-13.
19. Blaauw, B., Mammucari, C., Toniolo, L., Agatea, L., Abraham, R., Sandri, M., Reggiani, C. and Schiaffino, S. (2008) Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle. Hum. Mol. Genet., 17, 3686-3696.
20. Blaauw, B., Agatea, L., Toniolo, L., Canato, M., Quarta, M., Dyar, K.A., Danieli-Betto, D., Betto, R., Schiaffino, S. and Reggiani, C. (2010) Eccentric contractions lead to myofibrillar dysfunction in muscular dystrophy. J. Appl. Physiol., 108, 105-111.
21. Sampaolesi, M., Torrente, Y., Innocenzi, A., Tonlorenzi, R., D'Antona, G., Pellegrino, M.A., Barresi, R., Bresolin, N., De Angelis, M.G., Campbell, K.P. et al. (2003) Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science, 301, 487-492.
22. Disatnik, M.H., Chamberlain, J.S. and Rando, T.A. (2000) Dystrophin mutations predict cellular susceptibility to oxidative stress. Muscle Nerve, 23, 784-792.
23. Merlini, L., Angelin, A., Tiepolo, T., Braghetta, P., Sabatelli, P., Zamparelli, A., Ferlini, A., Maraldi, N.M., Bonaldo, P. and Bernardi, P. (2008) Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc. Natl Acad. Sci. USA, 105, 5225-5229.
24. Berlett, B.S. and Stadtman, E.R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem., 272, 20313-20316.
25. Michele, D.E. and Metzger, J.M. (2000) Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies. J. Mol. Med., 78, 543-553.
26. Bottinelli, R., Coviello, D.A., Redwood, C.S., Pellegrino, M.A., Maron, B.J., Spirito, P., Watkins, H. and Reggiani, C. (1998) A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ. Res., 82, 106-115.
27. Angelin, A., Tiepolo, T., Sabatelli, P., Grumati, P., Bergamin, N., Golfieri, C., Mattioli, E., Gualandi, F., Ferlini, A., Merlini, L. et al. (2007) Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc. Natl Acad. Sci. USA, 104, 991-996.
28. Tiepolo, T., Angelin, A., Palma, E., Sabatelli, P., Merlini, L., Nicolosi, L., Finetti, F., Braghetta, P., Vuagniaux, G., Dumont, J.M. et al. (2009) The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1(-/-) myopathic mice. Br. J. Pharmacol., 157, 1045-1052.
29. Reutenauer, J., Dorchies, O.M., Patthey-Vuadens, O., Vuagniaux, G. and Ruegg, U.T. (2008) Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Br. J. Pharmacol., 155, 574-584.
30. Svineng, G., Ravuri, C., Rikardsen, O., Huseby, N.E. and Winberg, J.O. (2008) The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function. Connect. Tissue Res., 49, 197-202.
31. Werner, E. and Werb, Z. (2002) Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J. Cell Biol., 158, 357-368.
32. Taddei, M.L., Parri, M., Mello, T., Catalano, A., Levine, A.D., Raugei, G., Ramponi, G. and Chiarugi, P. (2007) Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. Antioxid. Redox. Signal., 9, 469-481.
33. Di, L.F. and Bernardi, P. (2009) A CaPful of mechanisms regulating the mitochondrial permeability transition. J. Mol. Cell Cardiol., 46, 775-780.
34. Di, L.F., Kaludercic, N., Carpi, A., Menabo, R. and Giorgio, M. (2009) Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res. Cardiol., 104, 131-139.
35. Dorchies, O.M., Wagner, S., Vuadens, O., Waldhauser, K., Buetler, T.M., Kucera, P. and Ruegg, U.T. (2006) Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am. J. Physiol Cell Physiol, 290, C616-C625.
36. Benov, L., Sztejnberg, L. and Fridovich, I. (1998) Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic. Biol. Med., 25, 826-831.
37. Petronilli, V., Miotto, G., Canton, M., Brini, M., Colonna, R., Bernardi, P. and Di Lisa, F. (1999) Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J., 76, 725-734.
38. Rossi, R., Bottinelli, R., Sorrentino, V. and Reggiani, C. (2001) Response to caffeine and ryanodine receptor isoforms in mouse skeletal muscles. Am. J. Physiol. Cell Physiol., 281, C585-C594.